Cargando…

Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines

BACKGROUND: The phosphatidylinositol-3-kinase (PI3K-PKB), mitogen activated protein kinase (MEK-ERK) and the mammalian target of rapamycin (mTOR- p70S6K), are thought to regulate many aspects of tumour cell proliferation and survival. We have examined the utilisation of these three signalling pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Eun, Stones, Clare, Joseph, Wayne R, Leung, Euphemia, Finlay, Graeme J, Shelling, Andrew N, Phillips, Wayne A, Shepherd, Peter R, Baguley, Bruce C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352269/ https://www.ncbi.nlm.nih.gov/pubmed/22475322 http://dx.doi.org/10.1186/1471-2407-12-141

Ejemplares similares

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors
por: Stones, Clare J., et al.
Publicado: (2013)

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2013)

The Role of the Hippo Pathway in Melanocytes and Melanoma
por: Kim, Ji Eun, et al.
Publicado: (2013)

Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing
por: Sarkar, Debina, et al.
Publicado: (2017)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
por: Leung, Euphemia Y., et al.
Publicado: (2015)

Epigenetic regulation in human melanoma: past and future
por: Sarkar, Debina, et al.
Publicado: (2015)

Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines
por: Leung, Euphemia Y., et al.
Publicado: (2014)

Correction: Sarkar, D., et al. Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing. Int. J. Mol. Sci. 2017, 18, 1378
por: Sarkar, Debina, et al.
Publicado: (2018)

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
por: Leung, Euphemia Y., et al.
Publicado: (2017)

Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
por: Leung, Euphemia, et al.
Publicado: (2014)

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations
por: Leung, Euphemia Y., et al.
Publicado: (2018)

Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer
por: Hansji, Herah, et al.
Publicado: (2014)

Hormone Resistance in Two MCF-7 Breast Cancer Cell Lines is Associated with Reduced mTOR Signaling, Decreased Glycolysis, and Increased Sensitivity to Cytotoxic Drugs
por: Leung, Euphemia Yee, et al.
Publicado: (2014)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells
por: Leung, Euphemia, et al.
Publicado: (2011)

PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)
por: Medic, Sandra, et al.
Publicado: (2010)

Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival
por: D’mello, Stacey Ann N., et al.
Publicado: (2014)

ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells
por: Hansji, Herah, et al.
Publicado: (2016)

Characterization of Primary Cultures of Normal and Neoplastic Canine Melanocytes
por: Sforna, Monica, et al.
Publicado: (2021)

Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma
por: Tran, Khanh B., et al.
Publicado: (2020)

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets
Publicado: (1982)

A Comparative Transcriptomic Analysis of Uveal Melanoma and Normal Uveal Melanocyte
por: An, Jianhong, et al.
Publicado: (2011)

MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance
por: Gelmi, Maria Chiara, et al.
Publicado: (2022)

Dual or multiple drug loaded nanoparticles to target breast cancer stem cells
por: Gao, Yu, et al.
Publicado: (2020)

Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer
por: Askarian-Amiri, Marjan E., et al.
Publicado: (2014)

Melanoma in congenital melanocytic naevi
por: Kinsler, V.A., et al.
Publicado: (2017)

Melanoma Risk and Melanocyte Biology
por: BERTRAND, Juliette U., et al.
Publicado: (2020)

Mechanisms of differentiation in melanoma cells and melanocytes.
por: Bennett, D C
Publicado: (1989)

From Melanocyte to Metastatic Malignant Melanoma
por: Bandarchi, Bizhan, et al.
Publicado: (2010)

From Melanocyte to Malignant Metastatic Melanoma
por: Manga, Prashiela, et al.
Publicado: (2010)

Melanocyte and Melanoma Cell Activation by Calprotectin
por: Shirley, Stephanie H., et al.
Publicado: (2014)

The risk of cutaneous melanoma in melanocytic nevi
por: Fernandes, Nurimar Conceição
Publicado: (2013)

Depigmenting effect of Xanthohumol from hop extract in MNT-1 human melanoma cells and normal human melanocytes
por: Goenka, Shilpi, et al.
Publicado: (2021)

NMR metabolic fingerprints of murine melanocyte and melanoma cell lines: application to biomarker discovery
por: Santana-Filho, Arquimedes Paixão de, et al.
Publicado: (2017)

Fractal Dimension Analysis of Melanocytic Nevi and Melanomas in Normal and Polarized Light—A Preliminary Report
por: Popecki, Paweł, et al.
Publicado: (2022)

Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma
por: Gentien, David, et al.
Publicado: (2023)

Antibodies to normal human melanocytes in vitiligo
Publicado: (1983)

Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications
por: Welker, P, et al.
Publicado: (2000)

In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes
por: Gambichler, Thilo, et al.
Publicado: (2023)

Melanocytic naevi and melanoma in survivors of childhood cancer.
por: Green, A., et al.
Publicado: (1993)

Cytotoxic T lymphocyte responses against melanocytes and melanoma
por: Chang, Gwendolen Y, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_29naii6b8pdp6b90dt1bregn9j